| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |